Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size by Application
2.3.2 Market Size by Sales Channel
2.3.3 Market Size by End-User
2.4 Market Share & Bps Analysis by Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Software, AI & Digital Health Technology Providers
3.4.2 Digital Therapeutics Developers & Platform Providers
3.4.3 Healthcare Providers, Payers & Distribution Channels
3.4.4 End-Users & Patients
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Digital Therapeutics Technology & Platform Metrics
4.1.1 Share (%) of digital therapeutics platforms utilizing AI, mobile health applications, cloud computing, and data analytics globally.
4.1.2 Growth (%) in prescription digital therapeutics and software-based treatment solution deployments during 2025 and 2026.
4.1.3 Increase (%) in investments toward personalized, evidence-based, and remote patient care technologies worldwide.
4.2 Chronic Disease & Clinical Adoption Metrics
4.2.1 Share (%) of digital therapeutics demand generated from diabetes, mental health, cardiovascular, respiratory, and neurological disorder management globally.
4.2.2 Growth (%) in adoption of digital therapeutics across hospitals, clinics, and home healthcare settings worldwide.
4.2.3 Increase (%) in chronic disease prevalence and remote care demand driving digital therapeutics utilization globally.
4.3 Patient Engagement & Remote Monitoring Metrics
4.3.1 Share (%) of digital therapeutics usage delivered through smartphones, wearable devices, and connected healthcare platforms globally.
4.3.2 Growth (%) in telehealth integration and remote patient monitoring adoption worldwide.
4.3.3 Increase (%) in patient adherence and engagement through gamification, AI coaching, and personalized therapy solutions globally.
4.4 Regulatory, Reimbursement & AI Metrics
4.4.1 Share (%) of digital therapeutics solutions receiving regulatory approvals and reimbursement coverage globally.
4.4.2 Growth (%) in AI-enabled behavioral therapy, cognitive therapy, and digital mental health solution adoption worldwide.
4.4.3 Increase (%) in healthcare investments supporting cybersecurity, patient data privacy, and interoperable digital health ecosystems globally.
4.5 Regional Healthcare Digitization Metrics
4.5.1 Share (%) of global digital therapeutics spending concentrated across North America and Europe markets.
4.5.2 Growth (%) in regional digital health infrastructure and connected healthcare investments across emerging economies.
4.5.3 Increase (%) in partnerships between healthcare providers, pharmaceutical companies, and digital health technology firms globally.
5. Digital Therapeutics Market Segmental Analysis & Forecast, By Sales Channel, 2022–2035, Value (USD Billion)
5.1 Introduction
5.2 Business to Business
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022 – 2035
5.3 Business to Consumer
6. Digital Therapeutics Market Segmental Analysis & Forecast, By End-User, 2022–2035, Value (USD Billion)
6.1 Introduction
6.2 Patients
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022 – 2035
6.3 Providers
6.4 Payers
6.5 Employers
7. Digital Therapeutics Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)
7.1 Introduction
7.2 Diabetes
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022 – 2035
7.3 Obesity
7.4 Cardiovascular Disease
7.5 CNS Disease
7.6 Respiratory Disease
7.7 Smoking Cessation
7.8 Others
8. Digital Therapeutics Market Segmental Analysis & Forecast, By Region, 2022 – 2035, Value (USD Billion)
8.1 Introduction
8.2 North America
8.2.1 Key Trends
8.2.2 Digital Therapeutics Market Size & Forecast, By Sales Channel, 2022–2035
8.2.3 Digital Therapeutics Market Size & Forecast, By End-User, 2022–2035
8.2.4 Digital Therapeutics Market Size & Forecast, By Application, 2022–2035
8.2.5 Digital Therapeutics Market Size & Forecast, By Country, 2022–2035
8.2.5.1 USA
8.2.5.2 Canada
8.3 Europe
8.3.1 Key Trends
8.3.2 Digital Therapeutics Market Size & Forecast, By Sales Channel, 2022–2035
8.3.3 Digital Therapeutics Market Size & Forecast, By End-User, 2022–2035
8.3.4 Digital Therapeutics Market Size & Forecast, By Application, 2022–2035
8.3.5 Digital Therapeutics Market Size & Forecast, By Country, 2022–2035
8.3.5.1 Germany
8.3.5.2 UK
8.3.5.3 France
8.3.5.4 Italy
8.3.5.5 Spain
8.3.5.6 Russia
8.3.5.7 Poland
8.3.5.8 Rest of Europe
8.4 Asia-Pacific
8.4.1 Key Trends
8.4.2 Digital Therapeutics Market Size & Forecast, By Sales Channel, 2022–2035
8.4.3 Digital Therapeutics Market Size & Forecast, By End-User, 2022–2035
8.4.4 Digital Therapeutics Market Size & Forecast, By Application, 2022–2035
8.4.5 Digital Therapeutics Market Size & Forecast, By Country, 2022–2035
8.4.5.1 China
8.4.5.2 India
8.4.5.3 Japan
8.4.5.4 South Korea
8.4.5.5 Australia
8.4.5.6 ASEAN Countries
8.4.5.7 Rest of Asia-Pacific
8.5 Latin America
8.5.1 Key Trends
8.5.2 Digital Therapeutics Market Size & Forecast, By Sales Channel, 2022–2035
8.5.3 Digital Therapeutics Market Size & Forecast, By End-User, 2022–2035
8.5.4 Digital Therapeutics Market Size & Forecast, By Application, 2022–2035
8.5.5 Digital Therapeutics Market Size & Forecast, By Country, 2022–2035
8.5.5.1 Brazil
8.5.5.2 Argentina
8.5.5.3 Mexico
8.5.5.4 Colombia
8.5.5.5 Rest of Latin America
8.6 Middle East & Africa
8.6.1 Key Trends
8.6.2 Digital Therapeutics Market Size & Forecast, By Sales Channel 2022–2035
8.6.3 Digital Therapeutics Market Size & Forecast, By End-User, 2022–2035
8.6.4 Digital Therapeutics Market Size & Forecast, By Application, 2022–2035
8.6.5 Digital Therapeutics Market Size & Forecast, By Country, 2022–2035
8.6.5.1 UAE
8.6.5.2 Saudi Arabia
8.6.5.3 Qatar
8.6.5.4 South Africa
8.6.5.5 Rest of Middle East & Africa
9. Competitive Landscape
9.1 Key Players' Positioning
9.2 Competitive Developments
9.2.1 Key Strategies Adopted (%), By Key Players, 2025
9.2.2 Year-Wise Strategies & Development, 2022 – 2035
9.2.3 Number of Strategies Adopted by Key Players, 2025
9.3 Market Share Analysis, 2025
9.4 Product/Service & Application Benchmarking
9.4.1 Product/Service Specifications & Features by Key Players
9.4.2 Product/Service Heatmap by Key Players
9.4.3 Application Heatmap by Key Players
9.5 Industry Start-Up & Innovation Landscape
9.6 Key Company Profiles
9.6.1 Pear Therapeutics Inc.
9.6.1.1 Company Overview & Snapshot
9.6.1.2 Product/Service Portfolio
9.6.1.3 Key Company Financials
9.6.1.4 SWOT Analysis
9.6.2 Dario Health Corp.
9.6.3 Voluntis SA
9.6.4 Omada Health Inc.
9.6.5 Livongo Health (Teladoc)
9.6.6 Virta Health Corp.
9.6.7 Noom Inc.
9.6.8 One Drop (Lifecore Health)
9.6.9 Welldoc Inc.
9.6.10 Propeller Health (ResMed)
9.6.11 Big Health Ltd.
9.6.12 Limbix Health Inc.
9.6.13 Happify Health
9.6.14 Better Therapeutics Inc.
9.6.15 Click Therapeutics Inc.
9.6.16 Mahana Therapeutics
9.6.17 Twill Inc.
9.6.18 Kaia Health GmbH
9.6.19 Swing Therapeutics Inc.
9.6.20 Quit Genius (Moment Health)
10. Analyst Recommendations
10.1 SNS Insider Opportunity Map
10.2 Industry Low-Hanging Fruit Assessment
10.3 Market Entry & Growth Strategy
10.4 Analyst Viewpoint & Suggestions on Market Growth
11. Assumptions
12. Disclaimer
13. Appendix
13.1 List of Tables
13.2 List of Figures
Get in Touch
